Organization
First Affiliated Hospital of Guangxi Medical University
9 clinical trials
1 abstract
Abstract
Anti-LAG-3 antibody LBL-007 in combination with anti-PD-1 antibody tislelizumab with or without chemotherapy in patients with advanced nasopharyngeal cancer and other malignant tumors: A phase Ib/II dose escalation/expansion study.Org: The Affiliated Cancer Hospital of Guangxi Medical University, First Affiliated Hospital of Guangxi Medical University, First People’s Hospital of Yulin City,
Clinical trial
Efficacy and Safety of Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical CancerStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Neoadjuvant Treatment of Locally Advanced MSS Rectal Cancer With Tislelizumab Combined With CAPOX Regimen: a Prospective, Single-arm, Single-center, Exploratory Phase II Clinical StudyStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Edaravone in the Treatment of Aquaporin-4 Antibody-positive Optic NeuritisStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus#a Prospective, Multicenter, Single-arm Clinical StudyStatus: Recruiting, Estimated PCD: 2023-02-02
Clinical trial
Neoadjuvant Tislelizumab With Oxaliplatin and Capecitabine in Microsatellite Stable, Locally Advanced Colon Cancer: A Prospective, Single-arm, Single-center, Exploratory Phase II Clinical StudyStatus: Recruiting, Estimated PCD: 2026-11-30
Clinical trial
Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum DisorderStatus: Completed, Estimated PCD: 2022-12-31
Clinical trial
An Open Label Study Evaluating the Safety and Efficacy of Gene Therapy for Transfusion-dependent β-Thalassemia by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a LentiRed Lentiviral Vector (GMCN-508B Drug Product, Also Called LentiRed)Status: Recruiting, Estimated PCD: 2028-04-01
Clinical trial
A Phase 1 Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects With Transfusion-dependent α-Thalassemia by Transplantation of Autologous CD34+ Cells Transduced Ex Vivo With a Lentiviral Vector (GMCN-508A Drug Product)Status: Recruiting, Estimated PCD: 2028-08-01
Clinical trial
Study on the Efficacy and Safety of Henagliflozin Combined With Continuous Subcutaneous Insulin Infusion in the Treatment of Type 2 Diabetes Mellitus Based on Continuous Glucose Monitoring SystemStatus: Recruiting, Estimated PCD: 2024-07-01